References
- Hertz S, Roberst A. Radioactive iodine in the study of thyroid physiology. VII. The use of radioactive iodine therapy in hyperthyroidism. JAMA 1946; 131: 81–6
- Chapman EM, Evans RD. The treament of hyperthyroidism with radioactive iodine. JAMA 1946; 131: 86–91
- Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. JAMA 1946; 132: 838–47
- SSI rapport 2005:05 Helene Jönsson.
- Mattsson S, Johansson L, Jönsson H, Nosslin B. Radioactive iodine in thyroid medicine – how it started in Sweden and some of today's challenges. Acta Oncol 2006;45:1031–6.
- Holm L-E. Risk of thyroid cancer after exposure to radioactive 131-I. Acta Oncol 2006;45:1037–40.
- Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, et al. Risk of thyroid cancer after exposure to 131-I in childhood. J Natl Cancer Inst 2005; 97: 724–32
- Berg G. Radioiodine treatment for malignant thyroid disease. Acta Oncol 2006;45:1041–5.
- Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, et al. Post-surgical use of radioiodine 131-I in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: A consensus report. Eur J Endocrinol 2005; 153: 651–9
- Karlsson FA. Endocrine ophthalmopathy and radioiodine therapy. Acta Oncol 2006;45:1046–50.
- Bonnema SJ, Nielsen VE, Hegedüs L. Radioiodine therapy in nontoxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH). Acta Oncol 2006;45:1051–8.
- Hamilton TE, Davis S, Onstad L, Kopecky KJ. Hyperparahyroidism in persons exposed to iodine-131 from the Hanford Nuclear site. J Clin Endocrinol Metab 2005; 90: 6545–8
- Rasmuson T, Tavelin B. Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine. Acta Oncol 2006;45:1059–61.